U.S. Acellular Dermal Matrices Market – Rise in the Number of Surgical Procedures to Bolster Growth of the Market

Bio-derived, acellular dermal matrix lacks the presence of cells. Collagen and elastic fibers are the primary components of acellular dermal matrix. wound healing, breast reconstruction, cosmetic surgery, and plastic surgery have all benefited from the use of acellular dermal matrices in the recent past. Gingival grafting, dural repairs, tympanic membrane replacement, abdominal wall repair, and burn resurfacing were amongst the first applications of acellular dermal matrices. A spike in the number of surgical procedures in the US is projected to fuel the expansion of the U.S. acellular dermal matrices market in the years to come.

Development and Approval of Advanced Products to Drive Growth of the Market

Insurance companies’ have come up with favorable policies for breast reconstruction surgery in the US, which is likely to boost the US acellular dermal matrices market in the near future. The main players in the market are concentrating on the introduction along with approval of technologically improved acellular dermal matrices, which is likely to fuel market growth. For example, MedSkin Solutions Dr. Suwelack AG, a specialist biotech firm located in Germany, introduced two unique MatriDerm products in April 2021, which are MatriDerm Fenestrated Dermal Matrix and MatriDerm Flex Dermal Matrix. The two new solutions are part of MatriDerm’s expanding product line, which provides surgeons with more options for treating complicated injuries in one- and two-stage surgeries that include a split-thickness skin transplant.

Get Brochure of the Report HERE

In the near future, the U.S. acellular dermal matrices market is likely to be restrained in the near future due to problems and adverse effects connected with acellular dermal matrices in plastic and breast surgery. The development and approval of technologically sophisticated acellular dermal matrices in the market is likely to fuel market expansion in the years to come, according to key companies operating in the U.S. acellular dermal matrices market.